Second Sight Medical Products Inc
EYESW · NASDAQ
12/31/2024 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $1 | $3,379 |
| % Growth | -100% | -74% | -100% | – |
| Cost of Goods Sold | $0 | $0 | $1 | $2,152 |
| Gross Profit | $0 | $0 | $1 | $1,227 |
| % Margin | – | 50% | 50% | 36.3% |
| R&D Expenses | $15,745 | $2 | $5 | $13,143 |
| G&A Expenses | $8,932 | $6 | $6 | $9,226 |
| SG&A Expenses | $8,932 | $6 | $7 | $15,327 |
| Sales & Mktg Exp. | $0 | $0 | $1 | $6,101 |
| Other Operating Expenses | $0 | $0 | $4 | $3,354 |
| Operating Expenses | $24,677 | $9 | $15 | $31,824 |
| Operating Income | -$24,677 | -$9 | -$14,896 | -$33,954 |
| % Margin | – | -3,431.2% | -1,489,600% | -1,004.9% |
| Other Income/Exp. Net | $1,191 | $8,924 | $14,881 | $362 |
| Pre-Tax Income | -$23,486 | -$9 | -$15 | -$33,592 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23,486 | -$9 | -$15 | -$33,592 |
| % Margin | – | -3,431.2% | -1,488% | -994.1% |
| EPS | -0.43 | -0 | -0.001 | -1.02 |
| % Growth | -143,233.3% | 40% | 100% | – |
| EPS Diluted | -0.43 | -0 | -0.001 | -1.02 |
| Weighted Avg Shares Out | 54,981 | 32,817 | 32,817 | 32,817 |
| Weighted Avg Shares Out Dil | 54,981 | 32,817 | 32,817 | 32,817 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $16 | $362 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $164 | $397 |
| EBITDA | -$24,677 | -$8,933 | -$14,896 | -$33,954 |
| % Margin | – | -3,435,769.2% | -1,489,600% | -1,004.9% |